Arkolith/Insider Trading/TRIL/Form 4

Uger Robert

Chief Scientific OfficerTrillium Therapeutics Inc. (TRIL) · full profile →Form 4 · filed Jul 9, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$33K
Net Open-Market Flow
-$33K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2021Sell(S)4K$9.00$33K0
Jul 7, 2021Option exercise(M)4K$0.30$1K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2021Option exercise(M)4K—$0102K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-21-006419) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML